It should be highlighted that treatment with 2-hydroxypropyl-β-cyclodextrin (HPβCD) in the NPC1 murine model, an auspicious experimental therapy for NPC disease, has shown to increase sterol flow into the cytoplasm through independent mechanisms by NPC1 and NPC2 proteins [59]. The gene discussed is NPC1; the disease is nasopharyngeal carcinoma.